Healthcare
Cross Country Healthcare Inc(CCRN)
Live Price
Offline$13.17
+0.00% today
1Y Change
+1.15%
Window
Jun 25, 2025 β Jun 24, 2026
- Market Cap
- $340.00M
- Revenue Growth
- -21.6%
- EPS Growth
- -565.9%
- Dividend Yield
- 0.0%
Coverage: 250 bars Β· Jun 25, 2025 β Jun 24, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Cross Country Healthcare Inc (CCRN) is a Healthcare stock with a market cap of $340.00M and listed on NASDAQ. The stock last traded around $13.17 and up 1.1% across the available one-year price window (Jun 25, 2025 β Jun 24, 2026). Baseline metrics include revenue growth of -21.6%, EPS growth of -565.9%, a dividend yield of 0.0%. What stands out right now is revenue -21.6%, EPS -565.9%, free cash flow -64.0% with operating margin -0.3% and ROIC -0.9%. Valuation is more restrained than many high-expectation growth names at price/sales 0.3. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CCRN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-21.6% vs +7.6% peer median
Operating Margin
Below sector median
-0.3% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 6, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -21.6% and EPS is at -565.9%, with operating margin around -0.3%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +9.4% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS Ξ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 6, 2026 | β | +29.5% | +29.8% | +30.5% |
2026 Mar 4, 2026 | -300.0% | +8.3% | +7.1% | +2.1% |
2025 Nov 12, 2025 | -25.0% | -14.1% | -8.8% | -31.9% |
Benchmark Edge
CCRN vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CCRN
β
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CCRN Max Drawdown
-47.08%
Trailing 1Y
SPY Max Drawdown
β
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for CCRN and SPY.
Company Overview
Cross Country Healthcare Inc
NASDAQ
Cross Country Healthcare Inc. is a leading provider of workforce solutions to the healthcare sector in the United States. Its primary function is to offer staffing services including travel nurse and allied health staffing, per diem and permanent placement, as well as workforce management solutions to hospitals and healthcare facilities nationwide. This company plays a vital role in ensuring healthcare facilities can maintain optimal staffing levels, enhancing patient care and healthcare delivery across various settings. Cross Country Healthcare Inc. has an impactful presence in areas such as nursing, emergency medicine, and allied health, addressing the critical demand for healthcare professionals. By partnering with healthcare providers and professionals, Cross Country Healthcare actively contributes to mitigating staffing shortages and improving healthcare accessibility. Established in Boca Raton, Florida, the company leverages its industry expertise and expansive network to deliver comprehensive staffing solutions, making it a crucial component of the healthcare industryβs operational framework.
- Leadership
- Mr. John A. Martins
- Employees
- 9.6k
- Street Address
- 6551 Park of Commerce Boulevard, NW, Suite 160
- Mailing
- Boca Raton, FL, 33487
- Region
- Boca Raton, FL, United States
- Last Updated
- May 7, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- β
- EV/EBITDA
- 17.9
- Price/Sales
- 0.3
- Price/Book
- 1.1
Growth
- Revenue
- -21.6%
- EPS
- -565.9%
- Free Cash Flow
- -64.0%
Profitability
- Gross Margin
- 18.7%
- Operating Margin
- -0.3%
- Net Margin
- -9.0%
- ROE
- -24.3%
- ROIC
- -0.9%
Balance Sheet
- Debt/Equity
- 0.01
- Current Ratio
- 3.78
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.